We market well.

Your agency should fully understand your product and the science. Then, there’s the marketplace. Grasping all three dynamics is a specialized field. Ours.

Our philosophy implies there are no excuses for boring and dull. The medical industry deserves better.

Spread the word. Big or small. Any time, any place. Right now, today. Don’t wait, hesitate or ruminate. We can help all medical companies. We’d like to make your brand our next success story.

A CASE STUDY CLICK HERE
to review a copy of the book
NOW IN PROGRESS
World’s 2nd most popular
search engine? YouTube.

People are naturally interested in other humans and information.
Attract, educate and engage with videos that tell your story—just keep it brief.
SEE MORE
recent work right here
The Medical News
WASHINGTON (Reuters) - U.S. President Donald Trump acknowledged that a lack of support from four Senate Republicans leaves the party's healthcare overhaul on a "very, very narrow path" to win passage, but signaled a willingness to work with them to make changes.... ZURICH (Reuters) - A European Medicines Agency (EMA) panel recommended on Friday approving Novartis's Kisqali drug, bolstering the Swiss drugmaker's bid to challenge rival Pfizer's Ibrance against tough-to-treat breast cancer.... PORT-AU-PRINCE, Haiti (Reuters) - The United Nations stressed on Thursday its support for eradicating cholera in Haiti, an epidemic it accidentally started, although the government said residents would be better served if aid funding was channeled through it.... FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral multiple sclerosis (MS) drugs in Europe, six years after its first attempt to launch the cladribine pill failed.... (Reuters) - European regulators on Friday recommended the approval of Aveo Pharmaceuticals Inc's drug to treat kidney cancer, marking a big victory for the U.S. biotech that has faced a number of setbacks in bringing the drug to the market.... FRANKFURT (Reuters) - European regulators have recommended approval of a second copy of AbbVie's rheumatoid arthritis drug Humira, the world's top-selling medicine, in a further boost for so-called biosimilars in the region.... JOHANNESBURG (Reuters) - South Africa reported an outbreak of highly pathogenic H5N8 bird flu at a farm in the Free State province, agricultural industry body group AgriSA said on Friday.... CHICAGO (Reuters) - The United States halted imports of fresh Brazilian beef on Thursday, the U.S. Department of Agriculture (USDA) said, after a high percentage of shipments failed to pass safety checks.... (Reuters) - Two U.S. studies on the effects of marijuana on drivers in states where it is allowed for recreational use came to different conclusions about whether it increases risks behind the wheel.... LOS ANGELES (Reuters) - The parent of Burger King and Tim Hortons on Thursday vowed to cut the use of antibiotics in its chicken supply, joining other major fast-food chain operators in the battle against the rise of dangerous antibiotic-resistant bacteria known as superbugs....